PDL BioPharma, Inc. · Incline Village, NV United States ·(NASDAQ (GS): PDLI)
Company Description
View PDL BioPharma, Inc. Locations On A US Map
This link will open in a new window
This link will open in a new window If your body starts fighting you, PDL BioPharma hopes to help you fight back. The company's antibody (protein) humanization technology makes it possible to alter mouse monoclonal antibodies (MAbs) for improved use in therapies for humans, such as preventing and treating autoimmune diseases and cancer. The firm has licensed its technology to such companies as
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!
Key PDL BioPharma, Inc. Financials
| Company Type | Public - NASDAQ (GS): PDLI Headquarters |
| Fiscal Year-End | December |
| 2008 Sales (mil.) | $294.3 |
| 2008 Employees | 6 |
PDL BioPharma, Inc. Executives
9 executives listed for PDL BioPharma, Inc.'s Incline Village, NV location.
| Title | Name & Bio | Contact |
| President, CEO, and Director | John McLaughlin | Network |
| VP and CFO | Christine Larson | Network |
| VP Finance and Principal Accounting Officer | Karen Wilson | Network |
Competition
Competitive Landscape for PDL BioPharma, Inc.
Demand often depends on the income of consumers or the profitability of business customers, because many technology products and services are expensive. The profitability of individual companies is driven by their ability to develop and market new products. Large companies often have advantages in access to capital and marketing. Small companies can compete successfully if they have expertise in a particular field of knowledge. The industry is capital-intensive: average annual revenue per worker is nearly $300,000. To read the full description, subscribe now.Top PDL BioPharma, Inc. Competitors
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!